Introduction
Today's understanding of Helicobacter-related gastric diseases in humans stems from an explosion in research that occurred after the first culture of the organism by Marshall and Warren in 1982 (1) . Several risk factors for gastric cancer have been identified but the clinical outcome of Helicobacter pylori infection depends on host and bacterial factors. Helicobacter is a genus of gram-negative Epsilonproteobacteria usually found in the stomach. It is a human pathogen responsible for chronic active gastritis; infection by this organism is an important risk factor for peptic ulcers, gastric cancer, and gastric mucosa-associated lymphoid tissue lymphoma (2, 3, 4) . As symptoms are often absent or nonspecific in patients in the early stages of the disease, gastric cancer is usually diagnosed at an advanced stage, when curative options are limited. With exceptions in countries that have developed screening programs for early diagnoses, most patients with cancers reach treatment already in advanced stages (5) . The prevalence of H. pylori infection varies between countries; generally, the prevalence is about 30% in developed and more than 80% in developing countries (6) . However, the incidence of the cancer varies from region to region. In recent years, many H. pylori virulence factors have been characterized. The cytotoxin-associated gene pathogenicity island (cagPAI) and vacuolating cytotoxin gene A (vacA) are two identified virulence factors that are considered to have an important role in the pathogenesis of H. pylori infection (7) . cagPAI is a nearly 40-kb cluster of genes and is the most studied marker of H. pylori. There are 31 open reading frames predicted within the cag region.
One of these open reading frames encodes the immune dominant antigen CagA, which is localized to the -3′ end of the island. CagA was identified as the first protein of cagPAI and appeared to be a major virulence factor (8) . On the other hand, allelic variation can be seen in the vacA genotypes. Allelic variation among Helicobacter pylori vacA occurs in both the signal sequences (s region) and the midregion (m region) of the gene. Strains with genotype s1m1 produce high levels of vacuolating cytotoxin in vitro (9, 10) . However, strains with genotype s2 produce an inactive toxin (11).
Materials and methods

Sample collection
Our study was performed on 320 formalin-fixed, paraffinembedded (FFPE) tissues obtained from patients from the northwest of Iran and south of Turkey. For the Turkish population 80 paraffin blocks from patients with gastric adenocarcinoma and 80 paraffin blocks from patients with a nonadenocarcinoma diagnosis (chronic gastritis) were obtained from the pathology archive of the Pathology Department of the Medical Faculty of Çukurova University (Balcalı Hospital) according to the histopathological diagnosis reports. For the Iranian population the same numbers of samples as mentioned above were taken from the pathology archive of the Pathology Department of the Medical Faculty of Tabriz University of Medical Sciences (Imam Reza Hospital).
In order to determine the minimum amount of samples to obtain sufficient DNA for analysis, we collected five to seven 5-µm-thick cut sections from each selected paraffin block by using a new disposable blade for each sample on a semiautomatic microtome and placed them into 2.0-mL polypropylene microcentrifuge tubes for H. pylori DNA extraction. Deparaffinization (paraffin removal) procedures as a preextraction treatment were used for FFPE tissues according to guidelines by using xylene. To remove the residual xylene, the samples were washed several times with descending concentrations of ethanol. Finally, the tubes were kept open for evaporation of remaining ethanol (12). The DNA extraction procedure was performed with the QIAamp DNA Kit (QIAGEN Inc., Germany) according to the manufacturer's instructions. Prepared DNAs were stored at -20 °C. The total amount and purity of DNA for each sample were assessed by spectrophotometry (CHE BIOS, UV/Vis spectrophotometer). The total amount of DNA was obtained in ng/µL, and the A260/280 ratio was calculated for protein impurities. DNA was considered viable for amplification when the A260/A280 ratio value was from 1.7 to 2.0 (13).
PCR
PCR analyses were carried out to determine the presence or absence of cagA, cagE, cagT, cagG, cagM, vacA s1, vacA s2, vacA m1, and vacA m2 genes in each H. pylori-positive sample. All PCR mixtures were performed in a total volume of 25 µL. The glmM gene (urea C) was primarily amplified for detection of H. pylori DNA in our samples (14, 15) . In the rest of the study the amplification reactions for each positive sample for the glmM gene were performed by using specific primers and protocols (thermocycler: MJ Mini, Bio-Rad) for the detection of the considered genes (15) (16) (17) (18) . The sequences of primers used in this study and sizes of amplicons are described in Table 1 .
H. pylori 26695 DNA was used as a positive control for cagPAI-positive strains (14) . H. pylori-positive strains for genes selected in this study were used as a control for all the reactions performed (16) . All stages of this study were approved by the Ethics Committee of the Faculty of Medicine, Çukurova University, Adana, Turkey.
Detection of PCR products
For analysis of the amplified products of each PCR assay, 6 µL of the amplicons were electrophoresed with a 1X Tris-acetate-EDTA buffer on 2% agarose gel stained by ethidium bromide (5 µL/100 mL). The amplicons were visualized by UV transillumination and a 100-bp ladder was used as standard.
Results
From the 320 patients, H. pylori (presence of glmM) was detected in 91 patients (28.43%). Detailed demographic data for the presence of different cagPAI genes and vacA genotypes and histopathological findings are shown in Table 2 and Figures 1 and 2 .
Subsequently, combinations of genotypes were made and then compared between the two groups of patients, those with gastric adenocarcinoma and nonadenocarcinoma diagnosis, in the Iranian and Turkish patients of our study in order to understand the existence of probable relationships between the presence of various genes and the clinical and histopathological outcomes of diseases. Associations between the presence of cagPAI selected genes, vacA subtypes, and outcomes of disease are shown in Table 2 . Statistical differences in demographic characteristics among the different disease groups were determined by chi-square test (Table 2 ).
Discussion
Since the discovery of H. pylori, several studies have focused on elucidating the microorganism's pathogenicity mechanisms associated with clinical outcome. Gastric cancer is one of the most common worldwide cancers and is a highly lethal disease. Establishment of H. pylori as one of the risk factors for this kind of malignancy helps to identify high-risk individuals; however, infection with this organism is very common and most colonized people never develop cancer. Thus, techniques to identify high- (19) . In the present study, we used simple PCR for structural screening of selected cagPAI genes and vacA genotypes in clinical isolates of H. pylori in FFPE gastric biopsy specimens obtained from 320 patients suffering Based on previously published data, the prevalences of cagA in Iranian isolates were 62%, 92%, and 68.7% in Tehran, Jahrom, and Tabriz, respectively (20) (21) (22) (23) . According to statistical analysis, in our study area in Iran, there was no significant association between the presence of selected cagPAI genes, vacA subtypes, and gastric adenocarcinoma. However, the prevalence of some selected genes was questionably high in patients suffering from stomach adenocarcinoma and active chronic gastritis. In a recent study by Ghotaslou et al. in 2013, 68.7% of the Iranian patients were infected with cagApositive strains. On the other hand, in a current study from Turkey, Karaman et al. reported a cagA positivity rate of 65.5% and they also found a significant relationship between cagA status and peptic ulcer disease (22) . Saltık et al. reported the cagA positivity rate as 55.6% in 45 isolates and they found no significant difference between cagA positivity and the severity of gastroduodenal symptoms (24) . It is known that cagA positivity rates and their association with clinical outcomes differ from region to region. For example, studies from East and South Asian countries show that more than 90% of the strains carry the cagA gene regardless of clinical outcome. In general, the cagA prevalence rate has been found to be between around 50% to 70% in Middle Eastern countries, whereas in East Asian countries almost all isolated strains are cagApositive. According to our data the cagA positivity rate in Turkey for chronic gastritis and gastric adenocarcinoma was 57.14% and 78.94%, respectively, and these rates in Iranian patients were 81.48% and 58.8%.
The chaperone-like protein CagT plays an essential role in the translocation of cagA into host cells (25) and our results showed that the prevalence of cagT in Iranian strains was lower than in Turkey. This may be one of the reasons why cagA does not play a clear role in the formation of gastric adenocarcinoma in Iran.
Like cagA, cagE belongs to the cagPAI and it is responsible for binding to cell receptors and inducing the release of IL-8 (26) . In our samples cagE was found in 52.94% and 57.89% of Iranian and Turkish adenocarcinoma samples respectively and for chronic gastritis samples it was 37% and 32.1% in Iranian and Turkish patient samples, which reflects an important result, showing that this gene, like cagA, or in cooperation with cagA, may be related to the formation of active chronic gastritis and gastric cancer development in both countries. This study demonstrates that it is probable that infection with a cagE-positive H. pylori strain is associated with gastric disorders such as gastritis and adenocarcinoma in Iranian and Turkish patients in the selected areas. We found that cagE, not only cagA, could be used as a marker for the presence of cagPAI in our selected geographical regions.
Although the prevalence of strains positive for cagE, cagT, cagM, vacAs1, and vacAm2 in Iran and Turkey is similar, we can suggest that vacAs1, vacAm2, and cagA positivity be considered as essential virulence factors for the development of most severe gastric diseases, like gastric adenocarcinoma, in the Iranian and Turkish populations.
The results of the present study demonstrate that vacA subtypes s1 and m2 are dominant in Iran and Turkey, similar to other Middle East countries, and the frequencies of s1m2 in patients with active chronic gastritis and s1m1 in patients with adenocarcinoma were relatively high.
The s2m2 genotypes were much lower compared to other publications from Iran (27%) and also around the world (0%-57%) (27) .
Due to limitations in obtaining fresh endoscopy samples from patients, we used paraffin-embedded tissue blocks. Although formalin fixation with paraffin embedding is the universal method for tissue preservation and stabilization prior to histological evaluation by pathologists (28) , the effectiveness of PCR using DNA gained from FFPE tissue is affected by multiple factors, including the type of fixative used, the fixation time, the DNA extraction method, the length of the PCR target, the concentration of DNA, and the PCR protocol itself. Low percentages of extracted DNA and false negative responses are thus the main disadvantages of this method.
In conclusion, similar to studies performed in the Middle East, the association between cagA and cagE positivity and the virulence of H. pylori strains was remarkable among patients from the northwest of Iranian and south of Turkey with different disease outcomes. According to information obtained from this investigation, we can conclude that in patient groups selected from the south of Turkey and northwest of Iran it seems that the genes that were studied are homogeneous and in this era there is no significant difference in bacterial genetics. The results of this study indicate that cagA and vacAs1 are dominant in our studied area. However, in this population there is no statistically significant association between these factors and gastric cancer. It is possible that if the statistical population increases, the association of cagA with cancer might be meaningful. It can be concluded that with the exception of H. pylori infection other factors such as host genetics and nourishment play important roles in the formation of gastric cancer in the populations of our studied areas from Iran and Turkey. Considering the gap of information observed during our research relating to genotyping and other aspects of H. pylori infection, in order to achieve our goals further advanced molecular investigations like DNA sequencing analysis and studies of larger statistical populations from different geographical regions from Iran and Turkey are recommended.
